ArticleInfectious diseases and therapy2023

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Yu Hwa Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.